Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer
- 28 February 2002
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 28 (1) , 27-47
- https://doi.org/10.1053/ctrv.2002.0253
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Recommendation for Caution with Irinotecan, Fluorouracil, and Leucovorin for Colorectal CancerNew England Journal of Medicine, 2001
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerThe Lancet, 1998
- Colorectal cancer—Is there an alternative to 5-FU?European Journal Of Cancer, 1997
- Thymidylate synthase and drug resistanceEuropean Journal Of Cancer, 1995
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenaseEuropean Journal Of Cancer, 1994
- New targets for pyrimidine antimetabolites in the treatment of solid tumoursPharmacy World & Science, 1994
- Preclinical and clinical aspects of biomodulation of 5-fluorouracilCancer Treatment Reviews, 1994
- Prognostic factors in advanced colorectal carcinomaThe American Journal of Medicine, 1983